alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 

WASHINGTON, DC 20460 

MEMORANDUM 

DATE: 9/10113 

OFFICE OF 

CHEMICAL SAFETY AND POLLUTION 

PREVENTION 

SUBJECT: Foramsulfuron Immunotoxicity Waiver Request. 

PC Code: 122020 

Decision No.: 465379 

Petition No.: N/ A 

Risk Assessment Type: N/A 

TXR No.: 0056784 

MRID No.: N/A 

FROM: 

THRU: 

TO: 

Jaime D' Agostino, Toxicologist 

Risk Assessment Branch II 

Health Effects Division (7509P) 

Christina Swartz, Chief 

Risk Assessment Branch II 

Health Effects Division (7509P) 

Jose Gayoso 

DP Barcode: D414672 

Registration Nos.: NA 

Regulatory Action: Registration Review 

CaseNo.: NA 

CAS No.: 173159-57-4 

40CFR: N/A 

Risk Management and Implementation Branch II 

Pesticide Re-evaluation Division (7508P) 

I. CONCLUSION: The Health Effects Division (HED) agrees with the waiver request 

based on a decision to waive immunotoxicity studies for all sulfonylurea (SU) pesticides based 

on the minimal evidence ofimmunotoxidty in the available databases for SU pesticides, the 

liver, not the immune system is generally the target organ for this chemical class, points of 

departures based on the most sensitive endpoints obtained via the appropriate routes of exposure 

in the most sensitive species are currently used for dietary and non-dietary risk assessments, and 

there was no evidence of immunotoxicity with six other structurally-related sulfonylurea 

herbicides. (K. Rury, TXR# 0056723, 8/6/2013). 

II. ACTION REQUESTED: HED was asked to review a waiver request submitted by the 

registrant for an immunotoxicology study in conjunction with registration review for 

foramsulfuron. 

Page 1 of2 
III. BACKGROUND: Foramsulfuron (2-[[[[( 4,6-dimethoxy-2-

pyrimidiny 1 )amino ]carbony] amino ]sulfonyl] -4-(formylamino )-N ,N -dimethy lbenzamide) is a 

sulfonylurea herbicide registered for post-emergence use on field corn, sweet com, popcorn, and 

also for use on golf course turf, sports fields, commercial lawns, cemeteries, parks, campsites, 

recreational areas, home lawns, roadsides, school grounds, and sod farms to control cool season 

grasses from tolerant grasses and broadleafweeds. 

The registrant has requested a waiver for an immunotoxicity study in response to a registration 

review data call in. HED agrees with the waiver request based on a decision to waive 

immunotoxicity studies for all sulfonylurea pesticides as a class (K. Rury, TXR# 0056723, 

8/6/2013). 

Page2 of2
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                         1186651
<SECURITIES>                                   4404053
<RECEIVABLES>                                  2609319
<ALLOWANCES>                                    269000
<INVENTORY>                                     589915
<CURRENT-ASSETS>                               8726913
<PP&E>                                         7670003
<DEPRECIATION>                                 4614427
<TOTAL-ASSETS>                                16764650
<CURRENT-LIABILITIES>                          6374575
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        814377
<OTHER-SE>                                     6393829
<TOTAL-LIABILITY-AND-EQUITY>                  16764650
<SALES>                                        4914417
<TOTAL-REVENUES>                               4914417
<CGS>                                           868140
<TOTAL-COSTS>                                  7205513
<OTHER-EXPENSES>                                598942
<LOSS-PROVISION>                                269000
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (2859965)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (2859965)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (2859965)
<EPS-BASIC>                                      (.36)
<EPS-DILUTED>                                    (.36)


</TABLE>
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 456 Engrossed in House (EH)]

<DOC>
H. Res. 456

                In the House of Representatives, U. S.,

                                                          May 31, 2023.
    Resolved, That upon adoption of this resolution it shall be in order to 
consider in the House the bill (H.R. 3746) to provide for a responsible increase 
to the debt ceiling. All points of order against consideration of the bill are 
waived. The amendment printed in the report of the Committee on Rules 
accompanying this resolution shall be considered as adopted. The bill, as 
amended, shall be considered as read. All points of order against provisions in 
the bill, as amended, are waived. The previous question shall be considered as 
ordered on the bill, as amended, and on any further amendment thereto, to final 
passage without intervening motion except: (1) one hour of debate equally 
divided and controlled by the chair and ranking minority member of the Committee 
on Ways and Means or their respective designees; and (2) one motion to recommit.
            Attest:

                                                                          Clerk.
```
Michael HANEY, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D17-1674

District Court of Appeal of Florida, Second District.

May 22, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
Oliver RHODES, Appellant, v. STATE of Florida, Appellee.

No. 1D17-4623

District Court of Appeal of Florida, First District.

January 05, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Mr. Ronald W. Gore 

Chief, Air Division 

UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 

REGION 4 

ATLANTA FEDERAL CENTER 

61 FORSYTH STREET 

ATLANTA, GEORGIA 30303-8960 

. APR l 8 £(Hti 

Alabama Department of Environmental Management 

P.O. Box 301463 

Montgomery, Alabama 36130-1463 

Dear Mr. Gore: 

Enclosed is the fmal end-of-year report for your agency's FY 2015 Air Pollution Control grant 

authorized by § 105 of the Clean Air Act. This report outlines your agency's various grant commitments 

and their status. Since there were no issues and no adjustments necessary, your report is now finalized. 

This letter documents the conclusion of the joint evaluation process required by 40 Code of Federal 

Regulations 35.115 and identified as a commitment in your FY 2015 Air Planning Agreement under 

Cross Cutting Issues. 

We appreciate the progress you made in FY 2015 and look forward to continuing our joint efforts to 

protect and improve air quality. If you have any questions regarding your grant, please contact Stuart 

Pen·y at (404) 562-8980 or Gwendolyn Grafat (404) 562-9289. 

Enclosure 

Carol L. Kemker 

Acting Director 

Air, Pesticides and Toxics Management Division 

Internet Address (URL) • http://www.epa.gov 

Recycled/Recyclable • Printed with Vegetable Oil Based Inks on Recycled Paper (Minimum 30% Postconsumer)
****EXHIBIT 32.2**

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with theAnnual Report of Pimi Agro CleanTech, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2010as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Avi Lifshitz, Chief FinancialOfficer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

 
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

 
       April 12, 2011By:/s/ Avi Lifshitz   Avi Lifshitz   Chief Financial Officer 
 

43**
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 914 Engrossed in House (EH)]

<DOC>
H. Res. 914

                In the House of Representatives, U. S.,

                                                      December 7, 2023.
Whereas on September 30, 2023, as the House of Representatives was considering 
        legislation to avoid a lapse of appropriations for Federal agencies and 
        departments which would result in a shutdown of those agencies and 
        departments, Jamaal Bowman, the Representative from the 16th 
        Congressional District of New York, pulled a fire alarm;
Whereas section 22-1319 of the District of Columbia Criminal Code makes 
        knowingly causing a false alarm of fire a misdemeanor punishable by fine 
        or imprisonment up to six months, or both;
Whereas section 22-1319 of the District of Columbia Criminal Code states ``It 
        shall be unlawful for any person or persons to willfully or knowingly 
        give a false alarm of fire within the District of Columbia, and any 
        person or persons violating the provisions of this subsection shall, 
        upon conviction, be deemed guilty of a misdemeanor and be punished by a 
        fine not more than the amount set forth in section 22-3571.01 [of this 
        Code] or by imprisonment for not more than 6 months, or by both such 
        fine and imprisonment'';
Whereas on October 26, 2023, Representative Bowman pled guilty to violating 
        section 22-1319 of the District of Columbia Criminal Code and was 
        required to pay a $1,000 fine and write an apology letter to the United 
        States Capitol Police and was placed on probation; and
Whereas the actions of Representative Bowman forced the evacuation of the Cannon 
        House Office Building and disrupted the work of the Congress as a vote 
        was underway on the floor of the House: Now, therefore, be it
    Resolved, That--
            (1) the House of Representatives censures Jamaal Bowman, 
        Representative from the 16th Congressional District of New York;
            (2) Representative Jamaal Bowman will forthwith present himself in 
        the well of the House of Representatives for the pronouncement of 
        censure; and
            (3) Representative Jamaal Bowman will be censured with the public 
        reading of this resolution by the Speaker.
            Attest:

                                                                          Clerk.
```
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 731 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
H. RES. 731

Amending the Rules of the House of Representatives to modify the period 
  before the date of any primary election or general election during 
which a mass mailing is not frankable by a Member of the House who is a 
          candidate in such election, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 27, 2023

    Mr. Carey (for himself and Mr. Morelle) submitted the following 
   resolution; which was referred to the Committee on Rules, and in 
 addition to the Committee on House Administration, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                               RESOLUTION

 
Amending the Rules of the House of Representatives to modify the period 
  before the date of any primary election or general election during 
which a mass mailing is not frankable by a Member of the House who is a 
          candidate in such election, and for other purposes.

    Resolved,

SECTION 1. LIMITATIONS ON THE USE OF THE FRANK BEFORE A PRIMARY OR 
              GENERAL ELECTION.

    (a) In General.--Clause 8 of rule XXIV of the Rules of the House of 
Representatives is amended by striking ``less than 90 days before the 
date of a primary or general election (whether regular, special, or 
runoff) in which such individual is a candidate for public office'' and 
inserting ``on a date during the period described in section 
3210(a)(6)(A) of such title''.
    (b) House Communications Standards Commission Regulations and 
Guidance.--Not later than 30 days after the date of the adoption of 
this resolution--
            (1) the House Communications Standards Commission shall 
        update any relevant regulation or guidance to reflect the 
        amendment made by subsection (a); and
            (2) the Committee on House Administration shall make 
        publicly available on the website of the Committee any such 
        regulation or guidance updated under paragraph (1).

SEC. 2. CLARIFICATION WITH RESPECT TO JURISDICTION OF COMMITTEE ON 
              HOUSE ADMINISTRATION.

    Clause 1(k)(7) of rule X of the Rules of the House of 
Representatives is amended by striking ``Franking Commission'' and 
inserting ``House Communications Standards Commission''.
                                 <all>
```
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 986 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
H. RES. 986

  Condemning New York Governor Kathy Hochul for reducing funding for 
 schools across New York State and prioritizing increased funding for 
                               migrants.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 30, 2024

Mr. Molinaro (for himself, Ms. Stefanik, Mr. Garbarino, Mr. Langworthy, 
 Ms. Tenney, Mr. D'Esposito, Mr. LaLota, Mr. Lawler, Ms. Malliotakis, 
and Mr. Williams of New York) submitted the following resolution; which 
      was referred to the Committee on Education and the Workforce

_______________________________________________________________________

                               RESOLUTION

 
  Condemning New York Governor Kathy Hochul for reducing funding for 
 schools across New York State and prioritizing increased funding for 
                               migrants.

Whereas, on January 16, 2024, New York Governor Kathy Hochul announced the 
        fiscal year 2025 State budget, which is a record high 233 billion dollar 
        budget;
Whereas the proposed budget includes a new formula for school aid funding that 
        reduces funding for hundreds of schools across the State of New York;
Whereas such school aid funding cuts will ultimately lead to a decline in 
        disability services;
Whereas Governor Hochul's 2025 budget includes billions of dollars in additional 
        funds for the migrant crisis; and
Whereas the additional billions of dollars in funds for migrants will be used to 
        provide migrants with legal assistance, housing, transportation, health 
        care, and jobs: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) denounces Governor Kathy Hochul for reducing funding 
        for schools across New York State;
            (2) condemns Governor Hochul for allowing the border crisis 
        to displace students and harm their education; and
            (3) urges Governor Hochul to rescind her 2025 State budget 
        proposal and prioritize students over migrants by reversing the 
        funding cuts to schools.
                                 <all>
```
# Euroopan unionin C 32I/2021

| | ISSN 1977-1053 |
| --- | --- |
| Euroopan unionin
  virallinen lehti | C 032I |
| | |
| Suomenkielinen laitos | Tiedonantoja ja ilmoituksia | 64. vuosikerta29. tammikuu 2021 |

ISSN 1977-1053

Euroopan unionin

virallinen lehti

C 032I

Suomenkielinen laitos

Tiedonantoja ja ilmoituksia

64. vuosikerta29. tammikuu 2021

---

| Sisältö | Sivu |
| --- | --- |
| | IV   Tiedotteet |
| | EUROOPAN UNIONIN TOIMIELINTEN, ELINTEN, TOIMISTOJEN JA VIRASTOJEN TIEDOTTEET |
| | Euroopan komissio |
| 2021/C 32 I/01 | Tiivistelmä lääkkeiden myyntilupia koskevista Euroopan unionin päätöksistä 29 päivänä tammikuuta 2021(Julkaistu Euroopan parlamentin ja neuvoston asetuksen (EY) N:o 726/2004 13 tai 38 artiklan nojalla) | 1 |

Sisältö

Sivu

IV   Tiedotteet

EUROOPAN UNIONIN TOIMIELINTEN, ELINTEN, TOIMISTOJEN JA VIRASTOJEN TIEDOTTEET

Euroopan komissio

2021/C 32 I/01

Tiivistelmä lääkkeiden myyntilupia koskevista Euroopan unionin päätöksistä 29 päivänä tammikuuta 2021(Julkaistu Euroopan parlamentin ja neuvoston asetuksen (EY) N:o 726/2004 13 tai 38 artiklan nojalla)

(Julkaistu Euroopan parlamentin ja neuvoston asetuksen (EY) N:o 726/2004 13 tai 38 artiklan nojalla)

1

---

| FI | |
| --- | --- |

FI

---

IV Tiedotteet

EUROOPAN UNIONIN TOIMIELINTEN, ELINTEN, TOIMISTOJEN JA VIRASTOJEN TIEDOTTEET

Euroopan komissio

| 29.1.2021 | FI | Euroopan unionin virallinen lehti | CI 32/1 |
| --- | --- | --- | --- |

29.1.2021

FI

Euroopan unionin virallinen lehti

CI 32/1

---

Tiivistelmä lääkkeiden myyntilupia koskevista Euroopan unionin päätöksistä 29 päivänä tammikuuta 2021

(Julkaistu Euroopan parlamentin ja neuvoston asetuksen (EY) N:o 726/2004 13 tai 38 artiklan nojalla (1))

(2021/C 32 I/01)

| — | Myyntiluvan myöntäminen (Euroopan parlamentin ja neuvoston asetuksen (EY) N:o 726/2004 13 artikla): Hyväksytyt













  Päätöksen päivämäärä | Lääkkeen nimi | INN-nimi (kansainvälinen yleisnimi) | Myyntiluvan haltija | Yhteisön rekisteriin merkitty numero | Lääkemuoto | ATC-koodi (anatomis-terapeuttis-kemiallinen koodi) | Ilmoituksen päivämäärä |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 29.1.2021 | COVID-19 Vaccine AstraZeneca | COVID-19-rokote (ChAdOx1--S [rekombinantti]) | AstraZeneca AB |
| 151 85 Södertälje, Sverige |

—

Myyntiluvan myöntäminen (Euroopan parlamentin ja neuvoston asetuksen (EY) N:o 726/2004 13 artikla): Hyväksytyt

Päätöksen päivämäärä

Lääkkeen nimi

INN-nimi (kansainvälinen yleisnimi)

Myyntiluvan haltija

Yhteisön rekisteriin merkitty numero

Lääkemuoto

ATC-koodi (anatomis-terapeuttis-kemiallinen koodi)

Ilmoituksen päivämäärä

29.1.2021

COVID-19 Vaccine AstraZeneca

COVID-19-rokote (ChAdOx1--S [rekombinantti])

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/21/1529

Injektioneste, suspensio

J07BX03

29.1.2021

Kyseisten lääkkeiden julkiseen arviointilausuntoon ja siihen liittyviin päätöksiin voi tutustua ottamalla yhteyttä seuraavaan osoitteeseen:

| European Medicines Agency |
| --- |
| Domenico Scarlattilaan 6 |
| 1083 HS Amsterdam |
| NETHERLANDS |

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS

---

(1)  EUVL L 136, 30.4.2004, s. 1.

---
Lee W. SOWELL, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-1548

District Court of Appeal of Florida, Second District.

Opinion filed October 13, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
# Materials Not Included in **Airworthiness Directive (AD) Docket**

Docket Number: FAA- 2011 - 0216 Directorate Identifier: 2010NM197AD

AMM 54 - 50 - 00, R19 --- 7/15/10

Name/Description of Item(s) Not Included in FDMS Docket and Maintained in the Supplemental AD Docket 

### MA **Y BE VIEWED AT:** Federal Aviation Administration

Transport Airplane Directorate Rules Docket 1601 Lind Ave. SW., Renton, WA 98057 425.227.1221 **DURING THE HOURS OF:** 9 a.m. and 3 p.m., Monday through Friday, except Federal holidays. Form Date: 03/05/2008
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                            3515
<SECURITIES>                                         0
<RECEIVABLES>                                       19
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                  3533
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                    3533
<CURRENT-LIABILITIES>                              118
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                        3416
<TOTAL-LIABILITY-AND-EQUITY>                      3533
<SALES>                                              0
<TOTAL-REVENUES>                                    90
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                   164
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                   (74)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                               (74)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (74)
<EPS-BASIC>                                        0
<EPS-DILUTED>                                        0


</TABLE>
EXHIBIT 32.1

                 CERTIFICATE PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

     Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and in connection
with  the  Quarterly Report on Form 10-Q of Concurrent Computer Corporation (the
"Corporation")  for  the  quarter  ended  March  31,  2005,  as  filed  with the
Securities  and  Exchange  Commission  on  the  date  hereof (the "Report"), the
undersigned,  the  President  and  Chief  Executive  Officer  of the Corporation
certifies that:

     (1)  The  Report  fully  complies  with  the  requirements of Section 13(a)
          or 15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in  the  Report  fairly  presents, in all
          material respects, the financial condition and results of operation of
          the Corporation.


May 5, 2005



                                            /s/ T. Gary Trimm
                                           ------------------------
                                           T. Gary Trimm
                                           President and Chief Executive Officer
                                           (Principal Executive Officer)
Mario G. PONCE, Appellant, v. STATE of Florida, Appellee.

Case No. 2D17-1148

District Court of Appeal of Florida, Second District.

Opinion filed September 6, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.